News

NTNU, College of Management Welcomes the University of Lille Delegation to Strengthen International Collaboration

On December 3, the College of Management at National Taiwan Normal University (NTNU) warmly welcomed a delegation from the University of Lille, France. The delegation included Prof. Nil Toulouse, Vice President for International Affairs, Prof. Pascal Grandin, Dean of the College of Management, and Ms. Arielle Meunier, International Exchange Coordinator.

NTNU and Leadtek Deepen Ties for Deep Learning Innovation

NTNU and Leadtek Research Inc. have joined forces to create the Deep Learning Joint Laboratory, an initiative designed to advance the integration of deep learning technologies in education and industry. This partnership aims to bridge academic research and practical applications, driving innovation and industrial progress in Taiwan.

NTNU to Launch English-Taught Program in Business Administration (BA-ETP) in 2025

National Taiwan Normal University (NTNU) has announced the launch of its English-Taught Program in Business Administration (BA-ETP), set to commence in August 2025. This innovative program, housed within the AACSB-accredited College of Management, represents a significant step forward in international business education, offering a comprehensive English-language curriculum designed to develop globally-minded business professionals.

NTNU President Signs Agreement to Strengthen U.S.-Taiwan Language Education Cooperation at ACTFL 2024

NTNU President Cheng-Chih Wu signed a letter of intent with ACTFL Chair Dr. L. J. Randolph Jr. to strengthen collaboration in language education between Taiwan and the United States during the 2024 American Council on the Teaching of Foreign Languages (ACTFL) Annual Conference, held from November 22 to 24 in Philadelphia.

Big Data Confirms that Methylphenidate is good for reducing ADHD Mortality in the Long Term

Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent neurodevelopmental disorder in children and adolescents, significantly impacting cognitive learning and social interactions. Methylphenidate (MPH) is the primary pharmacological treatment for ADHD; however, parents’ concerns about potential side effects, including self-harm and suicide, have posed substantial challenges for clinical management. Professor Tzu-Chi Lee from the Department of Health Promotion and Health Education at National Taiwan Normal University has pioneered research in Taiwan to clarify the relationship between MPH use and mortality rates. The findings reveal that individuals who use MPH exhibit lower overall mortality rates compared to those who do not. Additionally, earlier initiation of MPH treatment following an ADHD diagnosis, as well as long-term use of the medication, is associated with further reductions in mortality risk.